116 related articles for article (PubMed ID: 2733453)
21. Biphenotypic acute leukemia: a case report.
Zucchini A; Fattori PP; Lanza F; Ferrari L; Bagli L; Imola M; Ravaioli A; Papa S
J Biol Regul Homeost Agents; 2004; 18(3-4):387-91. PubMed ID: 15786709
[TBL] [Abstract][Full Text] [Related]
22. Rearrangement of immunoglobulin and T cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers.
Norton JD; Campana D; Hoffbrand AV; Janossy G; Coustan-Smith E; Jani H; Yaxley JC; Prentice HG
Leukemia; 1987 Nov; 1(11):757-61. PubMed ID: 3500372
[TBL] [Abstract][Full Text] [Related]
23. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
Drach J; Drach D; Glassl H; Gattringer C; Huber H
Cytometry; 1992; 13(8):893-901. PubMed ID: 1459006
[TBL] [Abstract][Full Text] [Related]
24. Use of terminal deoxynucleotidyl transferase in the diagnosis of leukemia.
Morse EE; Gaffney J; Donskoy E; Pisciotto P; Altman A; Quinn J; Goldschneider I
Ann Clin Lab Sci; 1983; 13(2):128-32. PubMed ID: 6344744
[TBL] [Abstract][Full Text] [Related]
25. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
[TBL] [Abstract][Full Text] [Related]
26. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
27. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
Ball ED; Graziano RF; Fanger MW
J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
[TBL] [Abstract][Full Text] [Related]
28. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
Tang YM
Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
[TBL] [Abstract][Full Text] [Related]
29. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
Langebrake C; Brinkmann I; Teigler-Schlegel A; Creutzig U; Griesinger F; Puhlmann U; Reinhardt D
Cytometry B Clin Cytom; 2005 Jan; 63(1):1-9. PubMed ID: 15624201
[TBL] [Abstract][Full Text] [Related]
30. A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China.
Zheng J; Wang X; Hu Y; Yang J; Liu J; He Y; Gong Q; Yao J; Li X; Du W; Huang S
Cytometry B Clin Cytom; 2008 Jan; 74(1):25-9. PubMed ID: 18061959
[TBL] [Abstract][Full Text] [Related]
31. Diversity of acute non-lymphocytic leukemia analyzed with monoclonal antibodies reactive with myeloid differentiation antigens.
Morishima Y; Morishita Y; Okumura M; Minami S; Ohno R
Jpn J Clin Oncol; 1986 Mar; 16(1):49-57. PubMed ID: 3702071
[TBL] [Abstract][Full Text] [Related]
32. Leu-9 (CD 7) positivity in acute leukemias: a marker of T-cell lineage?
Ben-Ezra J; Winberg CD; Wu A; Rappaport H
Hematol Pathol; 1987; 1(3):147-56. PubMed ID: 2472373
[TBL] [Abstract][Full Text] [Related]
33. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
Naghashpour M; Lancet J; Moscinski L; Zhang L
Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
[TBL] [Abstract][Full Text] [Related]
34. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
[TBL] [Abstract][Full Text] [Related]
35. Characterization of acute undifferentiated leukemia by combined analysis of plasma membrane-associated gamma-glutamyltranspeptidase and soluble terminal transferase.
Heumann D; Losa G; Barras C; Morell A; von Fliedner V
Blood; 1985 Aug; 66(2):255-8. PubMed ID: 2861868
[TBL] [Abstract][Full Text] [Related]
36. Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.
Gucalp R; Paietta E; Weinberg V; Papenhausen P; Dutcher JP; Wiernik PH
Br J Haematol; 1991 May; 78(1):48-54. PubMed ID: 2043481
[TBL] [Abstract][Full Text] [Related]
37. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
Paietta E; Van Ness B; Bennett J; Racevskis J; Gucalp R; Cassileth P; Wiernik PH
Br J Haematol; 1992 Oct; 82(2):324-31. PubMed ID: 1419814
[TBL] [Abstract][Full Text] [Related]
38. [Dynamic analysis of cell surface markers in acute leukemias unclassified with immunologic criteria].
Wang L; Zhang M; Song S
Zhonghua Nei Ke Za Zhi; 1996 Sep; 35(9):595-7. PubMed ID: 9592352
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous or sequential expression of lymphoid and myeloid phenotypes in acute leukemia.
Neame PB; Soamboonsrup P; Browman G; Barr RD; Saeed N; Chan B; Pai M; Benger A; Wilson WE; Walker IR
Blood; 1985 Jan; 65(1):142-8. PubMed ID: 3880643
[TBL] [Abstract][Full Text] [Related]
40. Surface marker analysis and karyotype distinguish acute biphenotypic leukemia from acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase.
Moscinski LC; Nowell PC; Hoxie JA; Berger MS; Prystowsky MB
Cancer; 1991 Nov; 68(10):2161-8. PubMed ID: 1913454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
